Skip to main content

Advertisement

Table 1 Schedule and doses of dacetuzumab in Cycle 1 and additional cycles

From: A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

  Dacetuzumab dose, mg/kg
Week 1 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Day 1 Day 4 Day 8 Day 15 Day 22 Day 29 Day 36
Cycle 1 1 2 4 8 8 8 Restage
Cycles 2-12 8 8 8 8 Restage